Dr. Zhenghong Gao is a distinguished scientist and strategic leader with over 15 years of experience in biomedical research and drug development. He specializes in precision delivery technologies (nanoparticle etc.) for large molecules like RNA, DNA, peptides, and conjugates, focusing on developing breakthrough therapeutics for diseases in the areas, such as central nervous system, gastrointestinal tract, and urinary tract, etc.
Dr. Gao has held leadership roles at Bayer’s AskBio, Michigan Medicine, and several Biotech Startups, contributing to multiple innovation and flagship strategic collaboration programs with leading industry partners, Investigational New Drug (IND) applications and First-In-Human (FIH) clinical trials. He has received multiple awards, including the Therapeutic Idea Award for ALS from the Department of Defense.
Dr. Gao has published over 40 articles in journals including Nature Nano, JACS and ACS Nano etc. He is a keynote speaker at various forums. He earned his Ph.D. from the University of Tokyo and trained at leading institutions like CNRS. Previously, he was a Principal Investigator and Assistant Professor at the University of Texas at Dallas, affiliated with UT Southwestern Medical Center.